Nancy Monroy‐Jaramillo

A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy

Valérie Tosch, Holger M. Rohde, Hélène Tronchère et al. · Human Molecular Genetics · 2006 · 131 citations · Full text

<i>HLA</i>-<i>A*02:01:01</i>/<i>-B*35:01:01</i>/<i>-C*04:01:01</i>Haplotype Associated with Lamotrigine-Induced Maculopapular Exanthema in Mexican Mestizo Patients

Ingrid Fricke-Galindo, Iris E. Martínez‐Juárez, Nancy Monroy‐Jaramillo et al. · Pharmacogenomics · 2014 · 49 citations

Interethnic Variability in <i>CYP2D6</i> , <i>CYP2C9</i> , and <i>CYP2C19</i> Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics

María-Eugenia G. Naranjo, Fernanda Rodrigues‐Soares, Eva Peñas‐Lledó et al. · OMICS A Journal of Integrative Biology · 2018 · 48 citations · Full text

Beliefs in vaccine as causes of autism among SPARK cohort caregivers

Éric Fombonne, Robin P. Goin‐Kochel, Brian J. O’Roak et al. · Vaccine · 2020 · 33 citations · Full text

Vaccination, Family Medicine, Preventive Medicine +8

Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease

Petra Yescas, Marisol López, Nancy Monroy‐Jaramillo et al. · Neuroscience Letters · 2010 · 31 citations

Mendelian Disorder, Genetics, Mexican Patients +5